title: Interventional strategies to manage heart failure in patients with cancer.
abstract: The unique clinical circumstances that are typically encountered by cardiology providers when caring for patients undergoing treatment for cancer require an in-depth understanding of the recommended treatments for the diagnosis and management of heart failure and ischemic heart disease. It is also recognized that there is not a broadly described clinical research basis from which to provide guidance when specific clinical decision making is required. Thus, it is imperative that cardiology and oncology closely collaborate when difficult patient decisions arise. Engaging each discipline together with active patient involvement in clinical care will undoubtedly provide optimal care for our patients.
authors.affiliation: University of Kansas Medical Center in Kansas City, Kansas City, MO, USA. cbporter@mac.md
authors.forename: Charles
authors.initials: C
authors.lastname: Porter
authors.forename: David
authors.initials: D
authors.lastname: Slosky
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002309:Cardiology; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D003191:Comprehensive Health Care; D004347:Drug Interactions; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D033183:Interdisciplinary Communication; D008297:Male; D008495:Medical Oncology; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D018579:Patient Selection; D018570:Risk Assessment
chemical_list: D000970:Antineoplastic Agents; D002317:Cardiovascular Agents